RARE Ultragenyx Pharmaceutical Inc. - Common Stock
$25,92
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$18–$40
35% of range
Analystenbewertung
BUY
25 analysts
Kursziel
$53
+104% upside
P/E (TTM)
-4.5
ROE
-1613.2%
Nettogewinnmarge
-85.4%
RARE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$25.92
Marktkapitalisierung
$2.55B
P/E (TTM)
-4.5
EPS (TTM)
$-5.83
Umsatz (TTM)
$673M
Dividendenrendite
—
ROE
-1613.2%
Verschuldungsgrad
—
52W-Spanne
$18 – $40
RARE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$673M
2016-12-31
→
2025-12-31
EPS
$-5.83
2020-12-31
→
2025-12-31
Freier Cashflow
$-472M
2016-12-31
→
2025-12-31
Margen
-85.4%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
RARE
Peer-Median
P/E (TTM)
-4.5
97.6
P/S (TTM) (K/V (TTM))
3.8
7.7
P/B (K/B)
-31.8
8.0
Price / FCF (Kurs / FCF)
-5.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
RARE
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-79.5%
—
Net Profit Margin (Nettogewinnmarge)
-85.4%
-51.7%
ROA
-37.9%
-44.2%
ROE
-1613.2%
-63.5%
ROIC
673.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
RARE
Peer-Median
Current Ratio (Liquiditätsgrad)
2.5
4.9
Quick Ratio
1.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
RARE
Peer-Median
Revenue YoY (Umsatz YoY)
20.2%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
22.8%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
20.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
RARE
Peer-Median
RARE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
25 Analysten
- Starker Kauf 8 32,0%
- Kauf 14 56,0%
- Halten 3 12,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
19 Analysten · 2026-08-15
Median
$46.00
Mittelwert
$52.84
← Unter allen Zielen
$25.92
Tief
$27.00
Hoch
$96.00
Median-Ziel
$46.00
+77,5%
Mittelwert-Ziel
$52.84
+103,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.08%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.90 | $-1.24 | 0.34% |
| 31. März 2026 | $-1.84 | $-1.54 | -0.30% |
| 31. Dezember 2025 | $-1.29 | $-1.11 | -0.18% |
| 30. September 2025 | $-1.81 | $-1.26 | -0.55% |
| 30. Juni 2025 | $-1.17 | $-1.32 | 0.15% |
| 31. März 2025 | $-1.57 | $-1.65 | 0.08% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | — |
| COAG | — | — | — | — | — | — |
| KOD | $1.73B | -6.5 | — | — | -202.0% | — |
| KLRA | — | — | — | — | — | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Cost of Revenue | · | · | · | · | · | · | · | $1M | $1.0K | · | |
| R&D Expense | $750M | $698M | $648M | $706M | $497M | $412M | $357M | $294M | $232M | $183M | |
| SG&A Expense | $349M | $321M | $310M | $278M | $220M | $183M | $162M | $128M | $100M | $65M | |
| Operating Expenses | · | · | · | · | · | $601M | $528M | $423M | $332M | $248M | |
| Operating Income | $-535M | $-536M | $-569M | $-649M | $-382M | $-330M | $-424M | $-371M | $-329M | $-248M | |
| Interest Income | $25M | $37M | $27M | $11M | $2M | $7M | $13M | $10M | $4M | $4M | |
| Other Non-op | $1M | $-5M | $-1M | $-2M | $-2M | $607.0K | $-787.0K | $-6M | $7M | $-2M | |
| Pretax Income | $-571M | $-567M | $-609M | $-702M | $-453M | $-185M | $-399M | $-197M | $-318M | $-246M | |
| Income Tax | $4M | $2M | $-2M | $6M | $1M | $1M | $3M | $514.0K | $-16M | $35.0K | |
| Net Income | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| EPS (Basic) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| EPS (Diluted) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| Shares (Basic) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| Shares (Diluted) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| EBITDA | $-500M | $-500M | $-543M | $-631M | $-368M | $-318M | $-416M | $-352M | $-323M | $-245M |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $421M | $174M | $214M | $133M | $308M | $714M | $434M | $113M | $100M | $161M | |
| Short-term Investments | · | · | · | · | · | · | $322M | $346M | $134M | $219M | |
| Receivables | $158M | $122M | $73M | $40M | $28M | $23M | $33M | $13M | $5M | · | |
| Inventory | $52M | $45M | $34M | $27M | $16M | $13M | $12M | $7M | $757.0K | · | |
| Prepaid Expense | $61M | $40M | $48M | $69M | $72M | $58M | $51M | $43M | $29M | $20M | |
| Other Current Assets | · | · | $48M | $69M | · | · | · | · | · | · | |
| Current Assets | $951M | $817M | $732M | $884M | $857M | $1.30B | $851M | $522M | $270M | $402M | |
| PP&E (Net) | $244M | $266M | $291M | $260M | $141M | $74M | $44M | $20M | $22M | $17M | |
| PP&E (Gross) | $380M | $378M | $374M | $323M | $191M | $111M | $70M | $38M | $33M | $23M | |
| Accum. Depreciation | $136M | $112M | $83M | $63M | $50M | $37M | $26M | $18M | $11M | $6M | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | |
| Intangibles | $176M | $178M | $166M | $160M | $131M | $131M | $129M | $129M | $142M | · | |
| Other Non-current Assets | $60M | $63M | $58M | $48M | $21M | $9M | $3M | $4M | $3M | $2M | |
| Total Assets | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Accounts Payable | $31M | $39M | $42M | $43M | $17M | $13M | $13M | $12M | $9M | $5M | |
| Accrued Liabilities | $265M | $241M | $196M | $205M | $146M | $108M | $83M | $62M | $62M | $55M | |
| Current Liabilities | $384M | $344M | $280M | $261M | $181M | $190M | $103M | $75M | $71M | $60M | |
| Capital Leases | $24M | $30M | $31M | $20M | $30M | $39M | $30M | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $32M | $33M | $33M | $33M | $31M | $31M | · | |
| Other Non-current Liabilities | $44M | $17M | $12M | $5M | $1M | $7M | · | $5M | $5M | $6M | |
| Total Liabilities | $1.60B | $1.24B | $1.22B | $1.19B | $600M | $605M | $482M | $111M | $107M | $67M | |
| Common Stock | $0 | $0 | $82.0K | $70.0K | $69.0K | $67.0K | $58.0K | $51.0K | $44.0K | $41.0K | |
| Paid-in Capital | $4.45B | $4.21B | $3.66B | $3.14B | $3.00B | $2.77B | $2.09B | $1.64B | $1.22B | $1.00B | |
| Retained Earnings | $-4.53B | $-3.96B | $-3.39B | $-2.78B | $-2.07B | $-1.62B | $-1.43B | $-1.03B | $-833M | $-531M | |
| Treasury Stock | $8M | $4M | $432.0K | $0 | · | · | · | · | · | · | |
| AOCI | $1M | $-1M | $647.0K | $-7M | $-1M | $689.0K | $-147.0K | $-633.0K | $-6M | $905.0K | |
| Stockholders' Equity | $-80M | $255M | $275M | $352M | $923M | $1.15B | $654M | $609M | $383M | $474M | |
| Liabilities + Equity | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Shares Outstanding | 96,600,000 | 92,500,000 | 82,300,000 | 70,200,000 | 69,344,998 | 66,818,520 | 57,838,220 | 50,860,588 | 44,167,071 | 41,240,230 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $35M | $36M | $26M | $18M | $13M | $12M | $9M | $20M | $6M | $3M | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $68M | $48M | |
| Deferred Tax | · | $-1M | $-2M | $2M | · | · | $2M | · | $-16M | · | |
| Other Non-cash | $74M | $118M | $104M | $310M | $102M | $42M | $47M | $-112M | $-9M | $33M | |
| Operating Cash Flow | $-466M | $-414M | $-475M | $-380M | $-339M | $-132M | $-345M | $-291M | $-254M | $-161M | |
| CapEx | $6M | $7M | $44M | $116M | $73M | $44M | $25M | $4M | $3M | $10M | |
| Investing Cash Flow | $236M | $-18M | $168M | $-292M | $-195M | $-179M | $-13M | $-33M | $55M | $91M | |
| Stock Issued | · | · | · | $0 | $0 | $436M | $330M | $271M | · | · | |
| Net Stock Activity | · | · | · | $0 | · | $436M | $330M | $271M | · | · | |
| Financing Cash Flow | $478M | $399M | $388M | $501M | $119M | $600M | $679M | $337M | $136M | $139M | |
| Net Change in Cash | $252M | $-35M | $81M | $-172M | $-417M | $290M | $321M | $12M | $-62M | $69M | |
| Taxes Paid | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-472M | $-422M | $-519M | $-497M | $-412M | $-176M | $-370M | $-295M | $-257M | $-171M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% | -121.8% | -409.0% | -721.2% | -12593.5% | -186471.4% | |
| Net Margin | -85.4% | -101.6% | -139.7% | -194.7% | -129.2% | -68.8% | -388.3% | -383.8% | -11567.3% | -184867.7% | |
| Pretax Margin | -84.8% | -101.3% | -140.1% | -193.1% | -128.9% | -68.4% | -385.1% | -382.8% | -12187.5% | -184841.4% | |
| EBITDA Margin | -74.3% | -89.3% | -125.1% | -173.6% | -104.9% | -117.3% | -400.8% | -683.2% | -12370.5% | -183897.0% | |
| ROA | -37.9% | -38.0% | -40.0% | -46.1% | -27.7% | -12.9% | -43.4% | -32.6% | -58.6% | -44.7% | |
| ROE | -1613.2% | -189.1% | -395.0% | -172.3% | -48.9% | -20.5% | -58.3% | -31.1% | -70.5% | -48.9% | |
| ROIC | 673.4% | -210.5% | -206.1% | -185.6% | -41.5% | -28.8% | -65.4% | -61.2% | -81.4% | -52.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 | 6.8 | 8.2 | 7.0 | 3.8 | 6.7 | |
| Quick Ratio | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 | 3.9 | 7.6 | 6.3 | 3.4 | 6.3 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.3 | 0.0 | · | |
| Receivables Turnover | 4.8 | 5.7 | 7.6 | 10.6 | 13.6 | 9.7 | 4.6 | 5.7 | 1.0 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 20.2% | 29.0% | 19.4% | 3.4% | 29.7% | · | · | · | · | · | |
| Revenue CAGR 3Y | 22.8% | 16.8% | 17.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.0% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Net Income TTM | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| Market Cap | $2.22B | $3.89B | $3.94B | $3.25B | $5.83B | $9.25B | $2.47B | $2.21B | $2.05B | $2.90B | |
| P/E | -3.9 | -6.7 | -5.8 | -4.6 | -12.6 | -45.1 | -6.1 | -11.1 | · | · | |
| P/S | 3.3 | 6.9 | 9.1 | 9.0 | 16.6 | 34.1 | 23.8 | 42.9 | 784.3 | 21801.5 | |
| P/B | -27.8 | 15.2 | 14.3 | 9.2 | 6.3 | 8.0 | 3.8 | 3.6 | 5.3 | 6.1 | |
| P / Tangible Book | · | 117.9 | 61.2 | 22.1 | 7.8 | 9.4 | · | · | · | · | |
| P / Cash Flow | -4.8 | -9.4 | -8.3 | -8.5 | -17.2 | -70.0 | -7.2 | -7.6 | -8.1 | -18.0 | |
| P / FCF | -4.7 | -9.2 | -7.6 | -6.5 | -14.2 | -52.5 | -6.7 | -7.5 | -8.0 | -16.9 | |
| Earnings Yield | -25.4% | -14.9% | -17.2% | -21.8% | -8.0% | -2.2% | -16.4% | -9.0% | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $214M | $136M | $207M | $160M | $167M | $139M | $165M | $139M | $147M | $109M | $127M | $98M | $108M | $100M | $103M | $91M | |
| R&D Expense | $167M | $187M | $203M | $216M | $165M | $166M | $188M | $170M | $162M | $178M | $160M | $157M | $165M | $166M | $171M | $237M | |
| SG&A Expense | $88M | $88M | $88M | $87M | $87M | $87M | $82M | $80M | $81M | $78M | $77M | $75M | $81M | $77M | $73M | $70M | |
| Operating Income | $-75M | $-169M | $-113M | $-171M | $-108M | $-143M | $-122M | $-132M | $-116M | $-165M | $-122M | $-145M | $-148M | $-154M | $-146M | $-225M | |
| Interest Income | $5M | $6M | $7M | $6M | $6M | $7M | $10M | $11M | $7M | $9M | $9M | $6M | $6M | $6M | $6M | $3M | |
| Other Non-op | $1M | · | $-934.0K | $-1M | $2M | $837.0K | $-5M | $3M | $-2M | $-2M | $1M | $-699.0K | $-2M | $308.0K | $180.0K | $-1M | |
| Pretax Income | $-91M | $-184M | $-128M | $-180M | $-114M | $-150M | $-133M | $-133M | $-131M | $-170M | $-127M | $-159M | $-159M | $-163M | $-153M | $-239M | |
| Income Tax | $1M | $1M | $870.0K | $873.0K | $1M | $1M | $384.0K | $303.0K | $858.0K | $455.0K | $-4M | $650.0K | $732.0K | $495.0K | $-1M | $6M | |
| Net Income | $-92M | $-185M | $-129M | $-180M | $-115M | $-151M | $-133M | $-134M | $-132M | $-171M | $-124M | $-160M | $-160M | $-164M | $-152M | $-245M | |
| EPS (Basic) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| EPS (Diluted) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| Shares (Basic) | 101,900,000 | 100,600,000 | -195,920,392 | 99,771,297 | 98,500,000 | 96,300,000 | -175,860,804 | 95,493,996 | 86,580,516 | 84,286,292 | -139,430,962 | 71,664,493 | 70,897,991 | 70,368,478 | -139,581,974 | 70,054,173 | |
| Shares (Diluted) | 101,900,000 | 100,600,000 | -195,920,392 | 99,771,297 | 98,500,000 | 96,300,000 | -175,860,804 | 95,493,996 | 86,580,516 | 84,286,292 | -139,430,962 | 71,664,493 | 70,897,991 | 70,368,478 | -139,581,974 | 70,054,173 | |
| EBITDA | $-75M | $-161M | · | $-171M | $-108M | $-134M | · | $-132M | $-116M | $-157M | · | $-145M | $-148M | $-149M | · | $-225M |
Bilanz 28
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $175M | $421M | $203M | $176M | $127M | $174M | $151M | $481M | $112M | $214M | $73M | $102M | $86M | $133M | $392M | |
| Receivables | $200M | $121M | $158M | $113M | $124M | $99M | $122M | $93M | $106M | $100M | · | $79M | $71M | $43M | · | $31M | |
| Inventory | $59M | $55M | $52M | $52M | $46M | $46M | $45M | $43M | $40M | $36M | · | $32M | $28M | $27M | · | $22M | |
| Prepaid Expense | $55M | $68M | $61M | $53M | $61M | $60M | $40M | · | · | · | · | $46M | $51M | $67M | · | $71M | |
| Other Current Assets | · | · | · | · | · | · | · | $41M | $55M | $48M | · | · | · | · | · | · | |
| Current Assets | $606M | $657M | $951M | $643M | $720M | $699M | $817M | $800M | $965M | $596M | · | $599M | $702M | $766M | · | $1.01B | |
| PP&E (Net) | $235M | $239M | $244M | $250M | $256M | $261M | $266M | $272M | $279M | $285M | · | $297M | $289M | $278M | · | $235M | |
| PP&E (Gross) | · | · | $380M | · | · | · | $378M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $136M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | $44M | $44M | $44M | · | $44M | |
| Intangibles | $172M | $174M | $176M | $173M | $175M | $177M | $178M | $165M | $166M | $165M | · | $157M | $158M | $159M | · | $158M | |
| Other Non-current Assets | $63M | $61M | $60M | $58M | $60M | $62M | $63M | $54M | $54M | $60M | · | $28M | $26M | $22M | · | $18M | |
| Total Assets | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Accounts Payable | $39M | $42M | $31M | $41M | $34M | $47M | $39M | $36M | $60M | $41M | · | $33M | $42M | $59M | · | $24M | |
| Accrued Liabilities | $221M | $194M | $265M | $221M | $181M | $173M | $241M | $185M | $154M | $149M | · | $179M | $168M | $144M | · | $189M | |
| Current Liabilities | $351M | $325M | $384M | $340M | $293M | $292M | $344M | $285M | $273M | $246M | · | $254M | $244M | $218M | · | $227M | |
| Capital Leases | · | · | $24M | $22M | $25M | $28M | $30M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | · | $32M | $32M | $32M | · | $33M | |
| Other Non-current Liabilities | $41M | $42M | $20M | $19M | $17M | $17M | $17M | $16M | $15M | $14M | · | $10M | $10M | $9M | · | $4M | |
| Total Liabilities | $1.55B | $1.52B | $1.60B | $1.17B | $1.15B | $1.16B | $1.24B | $1.18B | $1.19B | $1.17B | · | $1.21B | $1.18B | $1.16B | · | $1.15B | |
| Common Stock | $0 | $0 | $0 | $96.0K | $96.0K | $94.0K | $0 | $92.0K | $92.0K | $83.0K | · | $72.0K | $71.0K | $71.0K | · | $70.0K | |
| Paid-in Capital | $4.52B | $4.48B | $4.45B | $4.41B | $4.37B | $4.25B | $4.21B | $4.17B | $4.12B | $3.70B | · | $3.30B | $3.24B | $3.17B | · | $3.11B | |
| Retained Earnings | $-4.81B | $-4.72B | $-4.53B | $-4.40B | $-4.22B | $-4.11B | $-3.96B | $-3.82B | $-3.69B | $-3.56B | · | $-3.26B | $-3.10B | $-2.94B | · | $-2.63B | |
| Treasury Stock | $10M | $10M | $8M | $8M | $8M | $8M | $4M | $4M | $3M | $3M | · | $381.0K | $381.0K | $356.0K | · | · | |
| AOCI | $0 | $0 | $1M | $820.0K | $-268.0K | $-341.0K | $-1M | $896.0K | $-1M | $-431.0K | · | $-2M | $-3M | $-4M | · | $-10M | |
| Stockholders' Equity | $-291M | $-236M | $-80M | $9M | $151M | $144M | $255M | $347M | $432M | $140M | $275M | $32M | $129M | $220M | $352M | $469M | |
| Liabilities + Equity | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Shares Outstanding | 98,600,000 | 98,300,000 | 96,600,000 | 96,442,027 | 96,353,634 | 93,903,785 | 92,500,000 | 92,304,317 | 92,135,384 | 83,094,037 | 82,300,000 | 72,174,307 | 71,465,424 | 70,660,249 | 70,197,297 | 70,079,777 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $9M | $9M | $9M | $9M | $10M | $9M | $9M | $9M | $8M | $7M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-20M | · | · | · | $-24M | · | · | · | $-29M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-97M | $-197M | $-100M | $-91M | $-108M | $-166M | $-79M | $-67M | $-77M | $-191M | $-84M | $-118M | $-116M | $-157M | $-90M | $-95M | |
| CapEx | $1M | $1M | $938.0K | $1M | $2M | $1M | $163.0K | $2M | $2M | $3M | $1M | $4M | $14M | $25M | $27M | $26M | |
| Investing Cash Flow | $44M | $-49M | $-72M | $117M | $71M | $120M | $103M | $-276M | $61M | $94M | $-107M | $64M | $99M | $111M | $-172M | $-162M | |
| Financing Cash Flow | · | · | $394M | $2.0K | $84M | $157.0K | $3M | $11M | $385M | $-58.0K | $330M | $25M | $33M | $-722.0K | $2M | $492M | |
| Net Change in Cash | $-49M | $-247M | $221M | $26M | $49M | $-45M | $24M | $-330M | $368M | $-97M | $140M | $-29M | $16M | $-46M | $-259M | $234M | |
| Free Cash Flow | · | $-198M | · | · | · | $-168M | · | · | · | $-194M | · | · | · | $-182M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -35.0% | -124.3% | · | -106.8% | -64.8% | -102.6% | · | -94.6% | -79.1% | -151.9% | · | -148.0% | -136.6% | -153.3% | · | -248.1% | |
| Net Margin | -43.0% | -136.0% | · | -112.8% | -69.0% | -108.5% | · | -95.7% | -89.5% | -156.8% | · | -162.8% | -147.6% | -163.2% | · | -270.2% | |
| Pretax Margin | -42.5% | -135.3% | · | -112.3% | -68.5% | -107.5% | · | -95.5% | -88.9% | -156.4% | · | -162.2% | -146.9% | -162.7% | · | -263.3% | |
| EBITDA Margin | -35.0% | -118.4% | · | -106.8% | -64.8% | -96.2% | · | -94.6% | -79.1% | -143.8% | · | -148.0% | -136.6% | -148.1% | · | -248.1% | |
| ROA | -7.2% | -14.2% | · | -13.2% | -7.9% | -11.5% | · | -9.6% | -9.0% | -12.7% | · | -11.2% | -12.2% | -11.8% | · | -15.8% | |
| ROE | 131.7% | 403.2% | · | -101.4% | -39.4% | -106.2% | · | -70.5% | -46.9% | -94.6% | · | -63.8% | -39.6% | -32.2% | · | -34.9% | |
| ROIC | 26.1% | 72.0% | · | -1874.9% | -71.9% | -100.0% | · | -38.1% | -27.1% | -118.2% | · | -459.4% | -115.2% | -70.1% | · | -49.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 2.0 | · | 1.9 | 2.5 | 2.4 | · | 2.8 | 3.5 | 2.4 | · | 2.4 | 2.9 | 3.5 | · | 4.5 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.0 | 0.8 | · | 0.9 | 2.1 | 0.9 | · | 0.6 | 0.7 | 0.6 | · | 1.9 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.6 | 1.4 | 1.4 | · | 1.6 | 1.7 | 1.5 | · | 1.8 | 2.0 | 2.8 | · | 3.2 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $677M | $601M | · | $605M | $592M | $535M | · | $493M | $462M | $416M | · | $398M | $389M | $360M | · | $342M | |
| Net Income TTM | $-572M | $-631M | · | $-580M | $-531M | $-587M | · | $-595M | $-622M | $-654M | · | $-729M | $-727M | $-720M | · | $-629M | |
| Market Cap | $3.29B | $2.06B | · | $2.90B | $3.50B | $3.40B | · | $5.13B | $3.79B | $3.88B | · | $2.57B | $3.30B | $2.83B | · | $2.90B | |
| P/E | -5.8 | -3.3 | · | -5.1 | -6.4 | -5.6 | · | -7.7 | -5.1 | -5.3 | · | -3.5 | -4.5 | -3.9 | · | -4.6 | |
| P/S | 4.9 | 3.4 | · | 4.8 | 5.9 | 6.4 | · | 10.4 | 8.2 | 9.3 | · | 6.5 | 8.5 | 7.9 | · | 8.5 | |
| P/B | -11.3 | -8.7 | · | 316.7 | 23.2 | 23.6 | · | 14.8 | 8.8 | 27.7 | · | 81.1 | 25.5 | 12.9 | · | 6.2 | |
| P / Tangible Book | · | · | · | · | · | · | · | 37.3 | 17.1 | · | · | · | · | 167.6 | · | 10.9 | |
| P / Cash Flow | · | -10.5 | · | · | · | -20.4 | · | · | · | -20.3 | · | · | · | -18.1 | · | · | |
| P / FCF | · | -10.4 | · | · | · | -20.3 | · | · | · | -20.0 | · | · | · | -15.6 | · | · | |
| Earnings Yield | -17.1% | -30.5% | · | -19.8% | -15.6% | -18.0% | · | -12.9% | -19.5% | -18.9% | · | -28.9% | -22.4% | -25.6% | · | -21.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $673M | $560M | $434M | $363M | $351M |
| Betriebsgewinnmarge % | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% |
| Nettoergebnis | $-575M | $-569M | $-607M | $-707M | $-454M |
| Verwässerte EPS | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 |
| Quick Ratio | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-472M | $-422M | $-519M | $-497M | $-412M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 346 Einreicher · $2.7B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 69 (+12 vs. Vorquartal) | 37 (-8 vs. Vorquartal) | 113 (-13 vs. Vorquartal) | 97 (+10 vs. Vorquartal) | +9.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $260.338.324 | 7.796.895 | 9,48% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $226.722.608 | 6.790.135 | 8,26% | Aktien |
| STATE STREET CORP | $205.641.197 | 6.158.766 | 7,49% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $143.459.834 | 4.296.491 | 5,22% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $120.911.868 | 3.621.200 | 4,40% | Aktien |
| SANDS CAPITAL MANAGEMENT, LLC | $105.457.908 | 3.158.368 | 3,84% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $98.157.217 | 2.939.719 | 3,57% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $95.092.590 | 2.847.936 | 3,46% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $73.869.758 | 2.211.828 | 2,69% | Aktien |
| Bellevue Group AG | $66.204.857 | 1.982.775 | 2,41% | Aktien |
| Sofinnova Investments, Inc. | $57.347.492 | 1.717.505 | 2,09% | Aktien |
| D. E. Shaw & Co., Inc. | $54.716.761 | 1.638.717 | 1,99% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $52.756.200 | 1.580.000 | 1,92% | Aktien |
| MPM BIOIMPACT LLC | $47.354.199 | 1.418.215 | 1,72% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $41.455.555 | 1.241.556 | 1,51% | Aktien |
| Candriam S.C.A. | $33.419.286 | 1.001.841 | 1,22% | Aktien |
| Rock Springs Capital Management LP | $32.316.678 | 967.855 | 1,18% | Aktien |
| Jefferies Financial Group Inc. | $31.040.212 | 929.626 | 1,13% | Aktien |
| Eagle Health Investments LP | $29.520.800 | 884.121 | 1,07% | Aktien |
| Qube Research & Technologies Ltd | $29.457.292 | 882.219 | 1,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $27.926.528 | 836.374 | 1,02% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $25.403.947 | 760.825 | 0,93% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.377.702 | 760.039 | 0,92% | Aktien |
| Caption Management, LLC | $24.000.732 | 718.800 | 0,87% | Verkaufsoption |
| BANK OF AMERICA CORP /DE/ | $23.505.893 | 703.980 | 0,86% | Aktien |
| Pictet Asset Management Holding SA | $23.159.948 | 753.695 | 0,84% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $22.418.413 | 671.411 | 0,82% | Aktien |
| GREAT POINT PARTNERS LLC | $20.034.000 | 600.000 | 0,73% | Verkaufsoption |
| Palo Alto Investors LP | $19.916.968 | 596.495 | 0,73% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $19.649.815 | 588.494 | 0,72% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $19.574.220 | 586.230 | 0,71% | Aktien |
| Trexquant Investment LP | $18.577.695 | 556.385 | 0,68% | Aktien |
| BlackRock, Inc. | $18.510.448 | 554.371 | 0,67% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.995.510 | 509.000 | 0,62% | Verkaufsoption |
| Sofinnova Investments, Inc. | $16.695.000 | 500.000 | 0,61% | Kaufoption |
| BNP PARIBAS FINANCIAL MARKETS | $16.633.796 | 498.167 | 0,61% | Aktien |
| TORONTO DOMINION BANK | $13.856.850 | 415.000 | 0,50% | Aktien |
| VANGUARD GROUP INC | $13.818.814 | 600.818 | 0,50% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $13.813.443 | 413.700 | 0,50% | Aktien |
| Caption Management, LLC | $13.753.341 | 411.900 | 0,50% | Kaufoption |
| Cutter Capital Management, LP | $13.734.562 | 379.303 | 0,50% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $13.624.489 | 408.041 | 0,50% | Aktien |
| ALGERT GLOBAL LLC | $13.020.898 | 389.964 | 0,47% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $12.735.614 | 381.420 | 0,46% | Aktien |
| AXA Investment Managers S.A. | $12.549.316 | 417.198 | 0,46% | Aktien |
| SummitTX Capital, L.P. | $12.496.875 | 374.270 | 0,46% | Aktien |
| GOLDMAN SACHS GROUP INC | $12.394.401 | 371.201 | 0,45% | Aktien |
| Privium Fund Management B.V. | $11.312.532 | 338.800 | 0,41% | Aktien |
| Squarepoint Ops LLC | $11.298.108 | 338.368 | 0,41% | Aktien |
| Walleye Capital LLC | $11.180.775 | 334.854 | 0,41% | Aktien |
| TWO SIGMA ADVISERS, LP | $11.076.800 | 481.600 | 0,40% | Aktien |
| Catalio Capital Management, LP | $10.559.654 | 316.252 | 0,38% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $9.944.000 | 297.819 | 0,36% | Aktien |
| Ensign Peak Advisors, Inc | $9.710.413 | 290.818 | 0,35% | Aktien |
| GordonMD Global Investments LP | $9.653.082 | 289.101 | 0,35% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.215.640 | 276.000 | 0,34% | Kaufoption |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $8.929.454 | 267.429 | 0,33% | Aktien |
| FMR LLC | $8.597.725 | 257.494 | 0,31% | Aktien |
| Quantinno Capital Management LP | $8.363.060 | 250.466 | 0,30% | Aktien |
| JPMORGAN CHASE & CO | $7.279.842 | 232.755 | 0,27% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $7.212.140 | 215.997 | 0,26% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $7.157.948 | 214.374 | 0,26% | Aktien |
| CITADEL ADVISORS LLC | $7.029.630 | 210.531 | 0,26% | Aktien |
| Ishara Investments LP | $6.844.950 | 205.000 | 0,25% | Aktien |
| Man Group plc | $6.508.245 | 194.916 | 0,24% | Aktien |
| FIFTH THIRD BANCORP | $6.452.150 | 193.236 | 0,23% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $6.396.789 | 191.578 | 0,23% | Aktien |
| Blue Owl Capital Holdings LP | $6.098.283 | 182.638 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.039.283 | 180.871 | 0,22% | Aktien |
| Woodline Partners LP | $5.736.569 | 171.805 | 0,21% | Aktien |
| Atom Investors LP | $5.735.434 | 171.771 | 0,21% | Aktien |
| Swiss National Bank | $5.597.900 | 167.652 | 0,20% | Aktien |
| Ikarian Capital, LLC | $5.529.952 | 165.617 | 0,20% | Aktien |
| Stonepine Capital Management, LLC | $5.500.000 | 200.000 | 0,20% | Kaufoption |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $5.260.270 | 171.456 | 0,19% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $5.229.275 | 156.612 | 0,19% | Aktien |
| Cubist Systematic Strategies, LLC | $5.194.035 | 172.674 | 0,19% | Aktien |
| Eversept Partners, LP | $5.146.401 | 154.130 | 0,19% | Aktien |
| MARSHALL WACE, LLP | $5.053.810 | 151.357 | 0,18% | Aktien |
| Ghisallo Capital Management LLC | $5.008.500 | 150.000 | 0,18% | Aktien |
| Mariner, LLC | $4.887.301 | 146.400 | 0,18% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $4.841.550 | 145.000 | 0,18% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $4.779.945 | 143.155 | 0,17% | Aktien |
| Corient Private Wealth LP | $4.644.350 | 139.094 | 0,17% | Aktien |
| SR One Capital Management, LP | $4.599.573 | 137.753 | 0,17% | Aktien |
| B Group, Inc. | $4.507.650 | 135.000 | 0,16% | Aktien |
| PINNACLE ASSOCIATES LTD | $4.377.563 | 131.104 | 0,16% | Aktien |
| Caption Management, LLC | $4.340.700 | 130.000 | 0,16% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $4.275.089 | 128.035 | 0,16% | Aktien |
| RHUMBLINE ADVISERS | $4.144.518 | 124.125 | 0,15% | Aktien |
| Apollon Wealth Management, LLC | $4.121.962 | 123.449 | 0,15% | Aktien |
| Odyssean, LLC | $4.076.485 | 122.087 | 0,15% | Aktien |
| Assenagon Asset Management S.A. | $4.035.649 | 120.864 | 0,15% | Aktien |
| EFG Asset Management (North America) Corp. | $3.848.509 | 127.985 | 0,14% | Aktien |
| BARCLAYS PLC | $3.742.919 | 112.097 | 0,14% | Aktien |
| IEQ CAPITAL, LLC | $3.540.194 | 106.026 | 0,13% | Aktien |
| Rafferty Asset Management, LLC | $3.394.260 | 101.655 | 0,12% | Aktien |
| Crestwood Advisors Group, LLC | $3.348.149 | 100.274 | 0,12% | Aktien |
| Tetragon Partners GP Ltd | $3.339.000 | 100.000 | 0,12% | Kaufoption |
| CITADEL ADVISORS LLC | $3.308.949 | 99.100 | 0,12% | Verkaufsoption |
Unternehmensinsider 28 Insider · 15 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Emil D Kakkis | President & CEO | 16. April 2026 A | 735.739 | 0 | 1 | $-1.240.411 |
| Howard Horn | Chief Financial Officer | 3. August 2026 S | 96.295 | 0 | 12 | $-1.332.021 |
| Mardi Dier | CFO & Executive Vice President | 14. Oktober 2022 S | 66.695 | 0 | 0 | $0 |
| Wladimir Hogenhuis | Chief Operating Officer | 4. Oktober 2019 F | 18.703 | 0 | 0 | $0 |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | 3. August 2026 S | 92.562 | 0 | 5 | $-487.890 |
| Eric Crombez | EVP and Chief Medical Officer | 5. Mai 2026 S | 111.189 | 0 | 2 | $-168.847 |
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | 22. April 2026 A | 68.911 | 0 | 4 | $-44.636 |
| Erik Harris | EVP & Chief Commercial Officer | 16. April 2026 A | 118.410 | 0 | 1 | $-240.289 |
| John Richard Pinion | EVP, Chief Quality Operations Officer | 16. April 2026 A | 133.142 | 0 | 1 | $-228.661 |
| Dennis Karl Huang | EVP, Chief Technical Operations Officer | 16. April 2026 A | 147.845 | 0 | 0 | $0 |
| Thomas Richard Kassberg | CBO & EVP | 3. März 2025 F | 264.730 | 0 | 0 | $0 |
| Camille L Bedrosian | EVP and Chief Medical Officer | 1. März 2023 S | 46.720 | 0 | 0 | $0 |
| Shalini Sharp | EVP, Finance | 14. Oktober 2020 S | 97.812 | 0 | 0 | $0 |
| Jayson Donald Alexander Dallas | EVP & Chief Commercial Officer | 1. Juni 2018 F | 23.830 | 0 | 0 | $0 |
| Sunil Agarwal | Chief Medical Officer | 21. Mai 2015 A | 29.400 | 0 | 0 | $0 |
| Corazon (Corsee) D. Sanders | Direktor | 15. Juni 2026 S | 21.095 | 0 | 1 | $-50.100 |
| Deborah Dunsire | Direktor | 14. Mai 2026 A | 38.566 | 0 | 0 | $0 |
| Daniel G Welch | Direktor | 14. Mai 2026 A | 40.441 | 0 | 0 | $0 |
| Amrit Ray | Direktor | 15. Mai 2025 A | 23.365 | 0 | 0 | $0 |
| Shehnaaz Suliman | Direktor | 15. Mai 2025 A | 25.940 | 0 | 0 | $0 |
| Lars Ekman | Direktor | 24. Juni 2022 A | 17.745 | 0 | 0 | $0 |
| William Aliski | Direktor | 24. Juni 2021 A | 66.849 | 0 | 0 | $0 |
| Clay B Siegall | Direktor | 10. August 2020 M | 2.550 | 0 | 0 | $0 |
| Eran Nadav | Direktor | 10. Juli 2014 A | — | 0 | 0 | $0 |
| Marten Steen | Direktor | 30. Januar 2014 A | — | 0 | 0 | $0 |
| Matthew K Fust | — | 14. Mai 2026 A | 33.696 | 0 | 0 | $0 |
| Michael Narachi | — | 14. Mai 2026 A | 40.441 | 0 | 0 | $0 |
| FMR LLC | — | 1. August 2014 J | 1.457.994 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 6. November 2020 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 48 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| TMFS · RBB Fund, Inc. | 3,03% | 74.931 NS | 31. Mai 2026 | N-PORT |
| GNOM · Global X Funds | 2,25% | 52.426 NS | 31. Mai 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,31% | 83.707 NS | 30. April 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,09% | 26.120 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,85% | 178.057 NS | 30. April 2026 | N-PORT |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,36% | 13.877 NS | 31. Mai 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 3.204 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,18% | 659.687 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,18% | 194.893 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,17% | 5.362 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,13% | 54.688 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,12% | 3.571 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 34.325 NS | 30. April 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,11% | 9.780 NS | 31. Mai 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 46.526 SH | 8. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,10% | 3.381 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 556.246 SH | 8. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1.238.640 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 46.723 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,09% | 491.706 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,08% | 2.451.260 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,07% | 395.227 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,05% | 59.639 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,05% | 14.131 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 463.045 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.127.405 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,04% | 2.146.622 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 251.571 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,04% | 4.391 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 39.736 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,03% | 10.374 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 5.097 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 4.961 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3.648 NS | 31. Mai 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 21.519 SH | 8. August 2026 | Täglich |
| GGUS · Goldman Sachs ETF Trust | 0,01% | 1.628 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 32.531 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 140.637 SH | 8. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 3.080 NS | 30. April 2026 | N-PORT |
| JUST · Goldman Sachs ETF Trust | 0,00% | 859 NS | 31. Mai 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,00% | 7.427 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 25.502 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 56.898 NS | 31. Mai 2026 | N-PORT |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 3.007 NS | 31. Mai 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 129 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.987.783 SH | 8. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 76.072 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.035 SH | 8. August 2026 | Täglich |